N. Reed

发表

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

D. Breen, T. Meyer, G. Poston, 2005, Gut.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours

M. Falconi, S. Partelli, J. Scoazec, 2017, Neuroendocrinology.

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

R. Sutton, A. Grossman, R. Thakker, 2005, Gut.

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

R. Jensen, M. Falconi, G. Klöppel, 2016, Neuroendocrinology.

Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG).

R. Pötter, E. Trimble, S. Pignata, 2007, International journal of radiation oncology, biology, physics.

Consensus guidelines update for the management of functional p-NETs (F-p-NETs) and non-functional p-NETs (NF-p-NETs)

M. Falconi, G. Kaltsas, G. Rindi, 2016 .

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

E. Baudin, B. Kos-Kudła, A. Sundin, 2017, Neuroendocrinology.

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

E. Krenning, F. Keleştimur, M. Pavel, 2016, Neuroendocrinology.

ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum

E. Krenning, F. Keleştimur, M. Pavel, 2016, Neuroendocrinology.

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

E. Van Cutsem, P. Rougier, B. Wiedenmann, 2004, Neuroendocrinology.

carcinoid) tumours gastroenteropancreatic neuroendocrine (including Guidelines for the management of

R. Sutton, A. Grossman, R. Thakker, 2005 .

Gut of UKNETwork for neuroendocrine tumours

R. Sutton, A. Grossman, R. Thakker, 2005 .

First-Line Therapy in Ovarian Cancer Trials

H. Kitchener, J. McAlpine, L. Rubinstein, 2011, International Journal of Gynecologic Cancer.

Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial.

T. Meyer, D. Talbot, D. Cunningham, 2016 .

Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)

A. Grossman, P. Ross, N. Reed, 2010, Regulatory Peptides.

British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice.

M. Hall, C. Fotopoulou, K. Hillaby, 2020, European journal of obstetrics, gynecology, and reproductive biology.

BGCS uterine cancer guidelines: Recommendations for practice.

A. Walther, C. Fotopoulou, P. Martin-Hirsch, 2017, European journal of obstetrics, gynecology, and reproductive biology.

NET-02: A multicenter, randomized, phase II trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients (pts) with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma (PD-EP-NEC).

J. Cave, Rohini Sharma, A. Lamarca, 2022, Journal of Clinical Oncology.

Overall and cancer specific survival following radical or adjuvant (chemo)radiotherapy in a retrospective cohort of elderly patients with endometrial cancer

N. Reed, P. McLoone, A. Sadozye, 2022, European Journal of Gynaecological Oncology.

Uterine Cancer Guidelines : Recommendations for Practice

J. Ledermann, S. Leeson, T. Mould, 2017 .

Patterns of Care for Radiotherapy in Vulvar Cancer: A Gynecologic Cancer Intergroup Study

R. Potter, E. Trimble, S. Pignata, 2009, International Journal of Gynecologic Cancer.

Clinical trials in gynecological cancer

E. Trimble, J. Ledermann, P. Disaia, 2006, International Journal of Gynecologic Cancer.

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

J. Cave, Rohini Sharma, D. Cairns, 2023, EClinicalMedicine.

Clinical trials in gynecological cancer.

E. Trimble, J. Ledermann, P. Disaia, 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

R. Sutton, A. Grossman, R. Thakker, 2005, Gut.